Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 12:11:1008.
doi: 10.3389/fphys.2020.01008. eCollection 2020.

Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy

Affiliations

Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy

Kathryn A Vera et al. Front Physiol. .

Erratum in

Abstract

Background: Sarcopenic obesity has been observed in people with neuromuscular impairment, and is linked to adverse health outcomes. It is unclear, however, if sarcopenic obesity develops in adults with facioscapulohumeral muscular dystrophy (FSHD).

Methods: The purpose of this study was to determine if adults with FSHD meet criteria for sarcopenic obesity (appendicular lean mass index (ALMI) scores of < 7.26 or 5.45 kg/m2; % fat mass (FM) ≥ 28 or 40% in men/women). Ten people with FSHD (50 ± 11 years, 2 females) and ten age/sex-matched controls (47 ± 13 years, 2 females) completed one visit, which included a full-body dual-energy x-ray absorptiometry (DXA) scan. Regional and whole body total mass, fat mass (FM), and lean mass (LM) were collected and body mass index (BMI) and sarcopenia measures were computed.

Results: People with FSHD and controls had a similar whole body total mass (84.5 ± 12.9 vs. 81.8 ± 13.5 kg, respectively, p = 0.65). Though BMI was 2% lower in the FSHD group (p = 0.77), the % FM was 46% higher in FSHD, compared with controls (p < 0.01). In addition, ALM volume was 23% lower (p = 0.02) and ALMI was 27% lower in FSHD compared with controls (p < 0.01). Whole body LM trended to be lower in FSHD vs. controls (p = 0.05), and arm and leg LM were both lower in FSHD compared with controls (p < 0.05). Furthermore, the % LM was 18% lower in FSHD vs. controls (p < 0.01). FSHD participants exhibited greater total body FM (p < 0.01) and total leg FM (p < 0.01), but were similar in volume of total arm FM compared with controls (p = 0.09).

Conclusion: Findings from this study suggest that people with FSHD, although similar in BMI and total body mass compared with controls, commonly meet the definition of sarcopenic obesity. Adults with co-existing FSHD and sarcopenic obesity may be at risk for significant impairments in quality of life, and encounter additional challenges in the management of FSHD manifestations.

Keywords: FSHD; appendicular lean mass index; body composition; muscular dystrophy; sarcopenic obesity.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Appendicular lean mass index (ALMI, kg/m2) in FSHD and controls. Individuals with FSHD had lower lean mass as compared to controls. Black circles indicate average data for each group. *p < 0.01.
FIGURE 2
FIGURE 2
% fat mass in FSHD and controls. Individuals with FSHD had a higher % fat mass, as compared to controls. Black circles indicate average data for each group. *p < 0.01.
FIGURE 3
FIGURE 3
% lean mass in FSHD and controls. Individuals with FSHD had a lower % lean mass, as compared to controls. Black circles indicate average data for each group. *p < 0.01.

Similar articles

Cited by

References

    1. Andries A., van Walsem M. R., Frich J. C. (2020). Self-reported physical activity in people with limb-girdle muscular dystrophy and Charcot-Marie-Tooth disease in Norway. BMC Musculoskelet. Disord. 21:235. 10.1186/s12891-020-03246-w - DOI - PMC - PubMed
    1. Androga L., Sharma D., Amodu A., Abramowitz M. K. (2017). Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Int. Rep. 2 201–211. 10.1016/j.ekir.2016.10.008 - DOI - PMC - PubMed
    1. Baumgartner R. N. (2000). Body composition in healthy aging. Ann. N. Y. Acad. Sci. 904 437–448. 10.1111/j.1749-6632.2000.tb06498.x - DOI - PubMed
    1. Baumgartner R. N., Heymsfield S. B., Roche A. F. (1995). Human body composition and the epidemiology of chronic disease. Obes. Res. 3 73–95. 10.1002/j.1550-8528.1995.tb00124.x - DOI - PubMed
    1. Baumgartner R. N., Wayne S. J., Waters D. L., Janssen I., Gallagher D., Morley J. E. (2004). Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12 1995–2004. 10.1038/oby.2004.250 - DOI - PubMed

LinkOut - more resources